Looming Patent Expiry of Blockbuster Drugs to Negatively Influence Demand for Hospital Pharmaceuticals Globally, Forecasts TMR
The looming patent expiry of blockbuster drugs and the need for maintaining the flow of novel therapeutics have led to realization that pharmaceutical companies cannot allow the status quo to remain as it is. Collaborating with other key players has thus become a popular strategy among leading enterprises vying to benefit from a stronger product pipeline.
View full press release